MORNING SESSION Chair (Ambassador Khaled Shamaa, Egypt) : He welcomes to the 6th Inter-Sessional meeting of the CND during its 57th session. As part of his role as Chair of the CND, he reported to the Third Committee of the General Assembly on the agenda item in international drug control, in particular on the work of the …
From NGO Statements
CND Inter-Sessional Session to discuss preparations for the UNGASS 2016 – 4 September 2014
MORNING SESSION Click here to view the presentations on UNGASS 2016. Chair (Ambassador Khaled Shamaa, Egypt): Began by introducing various procedural matters, and the agenda for the day was adopted. It is expected that UN General Assembly will adopt the UNGASS preparations resolution at their 69th Session. The Chair also encouraged Member States to invite civil society organisations …
CND intersessional – 10th June 2014
Member States gathered at the first intersessional since the 57th Session of the Commission on Narcotic Drugs to discuss issues related to UNGASS, law enforcement, HIV prevention and demand reduction, etc. A summary of the discussions is available below. Agenda item 1 – Consideration of Resolution 57/5 on UNGASS Chair. The chair urged civil society …
Harm Reduction International
I represent Harm Reduction International but am speaking on behalf of harm reduction organisations from around the world. In recent months we have been discussing what outcomes we want to see from the UNGASS on Drugs in 2016. We have condensed these into two main calls: First, the time has come for harm reduction to receive …
CND Day 4 – CADCA statement
Drug Policy Futures, Kevin Sabet: one of writers of 2012 OAS report but less happy on way it has been portrayed in media and by CS. We are part of DPF, promoting balanced approach based on health and appropriate role for LE, not dichotomy of war on drug or legalisation. Our demand for illegal drugs …
CND Day 4 – VNGOC statement
We have evidence based interventions which can greatly increase effectiveness of prevention, early intervention, harm reduction, treatment and recovery. But little evidence these are implemented. Evidence of strategies, but not of resources and implementations. We have evidence base, limited which need to be improved across 3 pillars of plan of action. Debate on effective drug …